RegulomeX
RegulomeX uses AI to map non-coding genome regions to identify drug targets. Its Regulatory Genome Language Model, RGenomeLM, analyzes regulatory elements in the dark genome to support target identification and validation. The platform is a B2B AI genomics analytics tool for pharma and biotech R&D teams. It leverages genomics analytics and machine learning to connect regulatory elements with therapeutic strategies. The solution aims to speed up discovery and enable more precise, personalized treatments at scale.
RegulomeX
RegulomeX uses AI to map non-coding genome regions to identify drug targets. Its Regulatory Genome Language Model, RGenomeLM, analyzes regulatory elements in the dark genome to support target identification and validation. The platform is a B2B AI genomics analytics tool for pharma and biotech R&D teams. It leverages genomics analytics and machine learning to connect regulatory elements with therapeutic strategies. The solution aims to speed up discovery and enable more precise, personalized treatments at scale.